These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16815477)

  • 1. Therapeutic potential of RNA interference for neurological disorders.
    Sah DW
    Life Sci; 2006 Oct; 79(19):1773-80. PubMed ID: 16815477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonviral siRNA delivery for gene silencing in neurodegenerative diseases.
    Prakash S; Malhotra M; Rengaswamy V
    Methods Mol Biol; 2010; 623():211-29. PubMed ID: 20217554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA interference based gene therapy for neurological disease.
    Jagannath A; Wood M
    Brief Funct Genomic Proteomic; 2007 Mar; 6(1):40-9. PubMed ID: 17478451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribonucleic acid interference for neurological disorders: candidate diseases, potential targets, and current approaches.
    Federici T; Boulis NM
    Neurosurgery; 2007 Jan; 60(1):3-15; discussion 15-6. PubMed ID: 17228249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: RNA interference--potential therapeutic applications for the gastroenterologist.
    Pellish RS; Nasir A; Ramratnam B; Moss SF
    Aliment Pharmacol Ther; 2008 May; 27(9):715-23. PubMed ID: 18248657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNAi: a novel antisense technology and its therapeutic potential.
    Dallas A; Vlassov AV
    Med Sci Monit; 2006 Apr; 12(4):RA67-74. PubMed ID: 16572063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference and potential therapeutic applications of short interfering RNAs.
    Karagiannis TC; El-Osta A
    Cancer Gene Ther; 2005 Oct; 12(10):787-95. PubMed ID: 15891770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribozymes and siRNA for the treatment of diseases of the nervous system.
    Wood MJ; Trülzsch B; Abdelgany A; Beeson D
    Curr Opin Mol Ther; 2003 Aug; 5(4):383-8. PubMed ID: 14513681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects of treating neurological diseases by gene therapy.
    Lundstrom K
    Curr Opin Investig Drugs; 2007 Jan; 8(1):34-40. PubMed ID: 17263183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference strategies as therapy for respiratory viral infections.
    DeVincenzo JP
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S118-22. PubMed ID: 18820571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference therapy for glioblastoma.
    Guo D; Wang B; Han F; Lei T
    Expert Opin Biol Ther; 2010 Jun; 10(6):927-36. PubMed ID: 20415602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense and RNA interference approaches to target validation in pain research.
    Kurreck J
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):179-87. PubMed ID: 15603251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allele-specific RNA interference for neurological disease.
    Rodriguez-Lebron E; Paulson HL
    Gene Ther; 2006 Mar; 13(6):576-81. PubMed ID: 16355113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA interference: a tool for querying nervous system function and an emerging therapy.
    Davidson BL; Boudreau RL
    Neuron; 2007 Mar; 53(6):781-8. PubMed ID: 17359914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting neurological disease with RNAi.
    Lingor P; Bähr M
    Mol Biosyst; 2007 Nov; 3(11):773-80. PubMed ID: 17940660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic RNA interference for neurodegenerative diseases].
    González-Alegre P
    Rev Neurol; 2008 Dec 16-31; 47(12):641-7. PubMed ID: 19085881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference as potential therapy for neurodegenerative disease: applications to inclusion-body myositis?
    Paulson H
    Neurology; 2006 Jan; 66(2 Suppl 1):S114-7. PubMed ID: 16432138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA knockdown as a potential therapeutic strategy in Parkinson's disease.
    Manfredsson FP; Lewin AS; Mandel RJ
    Gene Ther; 2006 Mar; 13(6):517-24. PubMed ID: 16267570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoproliferative disorders: prospects for gene therapy.
    Larsen SR; Rasko JE
    Pathology; 2005 Dec; 37(6):523-33. PubMed ID: 16373231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.